鲁抗医药非公开发行股票申请获证监会同意注册批复

Group 1 - The core point of the article is that LuKang Pharmaceutical (600789) has had its application for a non-public stock issuance approved and registered as effective [1] - The company plans to issue up to 270 million shares to no more than 35 specific investors, including Hualu Group [1] - The expected fundraising amount from this issuance is 1.2 billion yuan [1] Group 2 - The underwriting institution for this issuance is China International Capital Corporation [1]